Adar Poonawalla, CEO & Owner of Serum Institute of India, was the guest at ThePrint’s digital ‘Off the Cuff’. SII, the world’s largest vaccine manufacturer, has formed partnerships with multiple companies and institutes including Oxford University to develop a vaccine for Covid-19.
Adar Poonawalla said that very optimistically a potential vaccine could be produced by the end of the year and the Oxford trials are far ahead. He, however, raised caution saying that people’s expectations about the vaccine have to be managed as it isn’t till the third phase of the trial that the vaccine’s efficacy and safety can be gauged.
He also added, that as a deal-breaker with his partners he’s ensured that 50% of the vaccine they produce will be provided to India.